Related Articles Italian survey on the clinical management of non small cell lung cancer patients during the COVID 19 pandemic A lesson for the second wave Crit Rev Oncol Hematol 2020 Nov 27 157 103189 Authors Bertaglia V Reale ML Bironzo P Palesandro E Mariniello A Leone G Tabb F Bungaro M Audisio M Rapetti S Di Stefano RF Carnio S Artusio E Capelletto E Sperone P Passiglia F Novello S Abstract This study investigated the clinical management of non small cell lung cancer NSCLC patients during the first wave of coronavirus disease 2019 COVID 19 outbreak in Italy A 29 questions survey was sent to 95 Italian thoracic oncologists with 77 of them declaring significant changes in the outpatients management and treatment The results of this survey pointed out a significant delay of lung cancer diagnosis along with a relevant reduction of patients accrual within clinical trials Telemedicine emerged as a valid support for patient healthcare interactions Therapeutic indications followed the guidelines for adjuvant chemotherapy and concurrent chemo radiation Clinical indications to first line therapies were largely confirmed while major changes regarded the selection of second line treatment options as well as the management of elderly population This work may represent a valid source of information to improve the clinical management of NSCLC patients during second wave of COVID 19 pandemic PMID 33341505 PubMed as supplied by publisher